Trust Point Inc’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Sell
12,555
-11,062
-47% -$256K 0.03% 323
2026
Q1
$486K Sell
23,617
-1,337
-5% -$30.1K 0.04% 260
2025
Q4
$592K Buy
24,954
+220
+0.9% +$5.36K 0.05% 194
2025
Q3
$616K Sell
24,734
-1,167
-5% -$25.1K 0.05% 185
2025
Q2
$596K Sell
25,901
-13,015
-33% -$301K 0.06% 160
2025
Q1
$874K Sell
38,916
-2,286
-6% -$53.1K 0.08% 127
2024
Q4
$806K Buy
41,202
+72
+0.2% +$1.43K 0.06% 195
2024
Q3
$749K Buy
41,130
+1,386
+3% +$26.4K 0.06% 209
2024
Q2
$691K Sell
39,744
-1,180
-3% -$20.9K 0.06% 210
2024
Q1
$802K Buy
40,924
+15,527
+61% +$328K 0.06% 194
2023
Q4
$585K Buy
+25,397
New +$568K 0.05% 238

Other funds holding PRVA

Trust Point Inc's PRVA Position: Q2 2026 in Review

Trust Point Inc reduced its Privia Health (PRVA) stake by 47% in Q2 2026, selling an estimated $256K and leaving 12,555 shares worth $323K. The position accounts for 0.03% of the portfolio, ranked #323.

Trust Point Inc first reported a position in PRVA in Q4 2023 and has held it in 11 quarters since. The position peaked at $874K in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Trust Point Inc held 12,555 shares of Privia Health worth $323K as of Q2 2026.
  • Trust Point Inc sold 11,062 Privia Health shares in Q2 2026, an estimated $256K.
  • Privia Health made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #323 holding.
  • Trust Point Inc first reported a position in Privia Health in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Privia Health position peaked at $874K in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.